RT Journal Article
SR Electronic
T1 Association of Abnormal Cytology and risk factors in Women of Assam, India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.01.16.23284644
DO 10.1101/2023.01.16.23284644
A1 Barmon, Debabrata
A1 Sarma, Anupam
A1 Baruah, Upasana
A1 Kakoti, Lopamudra
A1 Barman, Debanjana
A1 Sarma, Pallavi
A1 Kalita, Manoj
A1 Rai, Avdhesh Kumar
YR 2024
UL http://medrxiv.org/content/early/2024/01/15/2023.01.16.23284644.abstract
AB The study was conducted to perform cytological abnormality screening by PAP test among women of Assam, India. Two hundred thirty four women in the age group of 35-60 years were enrolled in screening camps for the study. Smear on the glass slide of the cervical scrap specimen were prepared for PAP test. Statistical analysis for PAP test outcome with risk factors was analyzed by applying Fisher’s exact test. Significance was considered for p<0.05.It was found that women using contraceptive piles have higher risk of abnormal cytology (p-0.0238). Women with irregular menstrual cycle frequency have also higher risk of abnormal cytology (p-0.0002). Women not using commercially available sanitary pads ahe also high risk of abnormal cytology( p-0.0052). Women having urinary tract infection have also high risk of abnormal cytology (p-0.0102). Our study finding suggest that use of contraceptive pills, urinary infection, irregular frequency of menstrual cycle, non-use of sanitary pads may increase the risk of abnormal cytology positivity in women of Assam, India. There are limitations of our studyfindings because of small sample size and univariate statistical analysis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study didn't receive fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Dr Bhubaneswar Borooah Cancer Institute, Guwahati, Assam, INDIA gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in manuscript